Aranscia will provide software solutions to facilitate the delivery of results from InterVenn's flagship glycoproteomic liquid biopsy test.

The partnership marks Cardio Diagnostics' first expansion outside the US and is focused on integrating the test within Dr. Lal PathLabs' laboratory and clinical network.

Of the 30 companies in the index, 18 saw their share prices rise over the year, while 11 saw their stock prices decline and one remained flat.

Of the 30 companies in the index, 20 saw their share prices decline, while four saw their stock prices rise and two were flat month over month.

The organization updated its guidelines to account for changes in the illegal drug supply as well as advances in technologies used for drug detection.

The HRSA screening guidelines now recommend use of either clinician-collected or patient-collected samples for human papillomavirus testing.

The rapid molecular chlamydia and gonorrhea self-test provides results in 30 minutes from a self-collected swab sample, the firm said.

Last week, readers were most interested in a story about concerns around BillionToOne's Unity NIPT due to false negative results.

NEW YORK – Roche said Tuesday that its point-of-care test for the diagnosis of whooping cough and other Bordetella infections has received 510(k) clearance and CLIA waiver from the US Food and Drug ...

NEW YORK – Truvian announced Tuesday that it has received 510(k) clearance from the US Food and Drug Administration for its multimodal benchtop analyzer. The TruVerus instrument integrates clinical ...

NEW YORK – Diagnostics firm IdentifySensors Biologics has recently demonstrated proof of concept for the use of its electrochemical sensor-based diagnostic platform Check4 for cancer testing and is ...

NEW YORK – After rising 9 percent in October, the 360Dx Top 30 continued its upward momentum last month, rising an additional 9 percent in November. The 360Dx Top 30 outpaced the broader markets as ...